Viatris Inc(VTRS)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Viatris Inc (VTRS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores VTRS at 45.4/100 on a 32-signal composite quality model, placing it at rank #1,869 of 2,961 stocks — the bottom half of the AI-ranked universe. VTRS scores in the top quartile across revenue scale (89.9), institutional flow (85.2). Areas of concern include revenue growth (19.0) and profitability (30.0), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), Viatris Inc reports quarterly revenue of $3.8B, net income of $-118.8M, an operating margin of 0.2%. Top institutional holders of VTRS by reported 13-F value include FMR, BlackRock, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. VTRS trades on the Nasdaq exchange and files with the SEC under CIK 1792044. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate VTRS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Viatris Inc directly from SEC EDGAR.

AI Quality Score

45.4/100

AI Rank

#1,869

Revenue

$3.8B

Net Income

$-118.8M

Free Cash Flow

$329.0M

Operating Margin

0.2%

VTRS key financials by period

Viatris Inc reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$14.3B-18.6%
FY 202410-K$14.7B0.1%
FY 202310-K$15.4B5.0%
FY 202210-K$16.3B9.9%
FY 202110-K$17.9B-0.2%
FY 202010-K$11.9B-1.8%

Institutions holding VTRS

Institutional investors reporting a position in Viatris Inc on SEC Form 13F.
InstitutionSharesValueReported
FMR96,662,102$1.5B2026-06-30
BlackRock86,019,468$1.4B2026-06-30
VANGUARD CAPITAL MANAGEMENT76,046,939$1.2B2026-06-30
DAVIS SELECTED ADVISERS75,232,254$1.2B2026-06-30
PRICE T ROWE ASSOCIATES68,214,436$1.1B2026-06-30
VANGUARD PORTFOLIO MANAGEMENT54,282,080$862.0M2026-06-30
STATE STREET53,069,461$842.7M2026-06-30
Rubric Capital Management34,168,743$542.6M2026-06-30
GEODE CAPITAL MANAGEMENT32,807,906$520.1M2026-06-30
DIMENSIONAL FUND ADVISORS29,970,094$476.0M2026-06-30
VTRS

Viatris Inc

VTRS
NasdaqLarge CapHealthcare

13F Pro Quality Score

45.4/100

Rank #1,869 of 2,961 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

19.0/100

Profitability

30.0/100

Balance Sheet

30.0/100

Earnings Quality

30.0/100

Free Cash Flow

62.3/100

Institutional Flow

85.2/100

Revenue Scale

89.9/100

Dilution Risk

51.2/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$3.76B

Net Income

Q2 2026
EDGAR

$-118.80M

EPS (Diluted)

Q2 2026
EDGAR

$-0.10

Operating Margin

Q2 2026
EDGAR

0.2%

ROIC

Q2 2026
EDGAR

0.1%

Free Cash Flow

Q2 2026
EDGAR

$329.00M

Debt/Equity

Q2 2026
EDGAR

1.06

Top Institutional Holders

as of Q2 2026
$16.83B total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…